Bessemer Group Inc Biotechnology

Bessemer Group Inc

$55.8 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
AXSM Axsome Therapeutics, Inc.	$4.81B	$3,000 0.0% of portfolio	25	Q1 2025 Reduced 16.67%
HRTX Heron Therapeutics, Inc.	$238M	$3,000 0.0% of portfolio	1,300	Q1 2025 Reduced 8.77%
SMMT Summit Therapeutics Inc.	$5.6B	$3,000 0.0% of portfolio	135	Q1 2025 Reduced 6.9%
ALT Altimmune, Inc.	$199M	$2,000 0.0% of portfolio	398	Q1 2025 Added 4.74%
ACLX Arcellx, Inc.	$2.94B	$2,000 0.0% of portfolio	30	Q3 2024 New
IONS Ionis Pharmaceuticals Inc	$5.99B	$2,000 0.0% of portfolio	73	Q1 2025 New
KYMR Kymera Therapeutics, Inc.	$2.54B	$2,000 0.0% of portfolio	60	Q1 2025 Reduced 7.69%
LGND Ligand Pharmaceuticals Inc	$2.32B	$2,000 0.0% of portfolio	16	Q1 2025 Reduced 57.89%
MDGL Madrigal Pharmaceuticals, Inc.	$5.96B	$2,000 0.0% of portfolio	5	Q1 2025 Reduced 50.0%
NUVL Nuvalent, Inc.	$3.68B	$2,000 0.0% of portfolio	25	Q3 2024 New
VCYT Veracyte, Inc.	$1.73B	$2,000 0.0% of portfolio	55	Q1 2025 Reduced 99.56%
ADPT Adaptive Biotechnologies Corp	$1.5B	$1,000 0.0% of portfolio	78	Q1 2025 New
IOVA Iovance Biotherapeutics, Inc.	$369M	$1,000 0.0% of portfolio	169	Q1 2025 Reduced 3.43%
LQDA Liquidia Corp	$940M	$1,000 0.0% of portfolio	80	Q1 2025 Reduced 5.88%
NVAX Novavax Inc	$548M	$1,000 0.0% of portfolio	95	Q1 2025 New
PDSB Pds Biotechnology Corp	$34.2M	$1,000 0.0% of portfolio	1,146	Q4 2024 New
SNDX Syndax Pharmaceuticals Inc	$547M	$1,000 0.0% of portfolio	49	Q1 2025 New
AVXL Anavex Life Sciences Corp.	$862M	$0 0.0% of portfolio	1	Q1 2025 New
ARCT Arcturus Therapeutics Holdings Inc.	$360M	$0 0.0% of portfolio	16	Q1 2025 New
RCUS Arcus Biosciences, Inc.	$680M	$0 0.0% of portfolio	34	Q1 2025 New
AURA Aura Biosciences, Inc.	$208M	$0 0.0% of portfolio	31	Q1 2025 New
BCRX Biocryst Pharmaceuticals Inc	$1.62B	$0 0.0% of portfolio	0	Q1 2025 Sold Out
CAPR Capricor Therapeutics, Inc.	$175M	$0 0.0% of portfolio	26	Q1 2025 New
COGT Cogent Biosciences, Inc.	$802M	$0 0.0% of portfolio	63	Q1 2025 Reduced 65.0%
CVAC Cure Vac N.V.	$1.01B	$0 0.0% of portfolio	1	Q1 2025 New
EYPT Eye Point Pharmaceuticals, Inc.	$351M	$0 0.0% of portfolio	34	Q1 2025 Reduced 62.22%
GERN Geron Corp	$487M	$0 0.0% of portfolio	204	Q1 2025 Reduced 63.89%
IBRX Immunity Bio, Inc.	$1.13B	$0 0.0% of portfolio	50	Q2 2024 New
NUVB Nuvation Bio Inc.	$487M	$0 0.0% of portfolio	122	Q1 2025 New
REPL Replimune Group, Inc.	$616M	$0 0.0% of portfolio	33	Q1 2025 Reduced 72.5%
SAGE Sage Therapeutics, Inc.	$543M	$0 0.0% of portfolio	37	Q1 2025 New
SANA Sana Biotechnology, Inc.	$847M	$0 0.0% of portfolio	89	Q1 2025 New
VERV Verve Therapeutics, Inc.	$656M	$0 0.0% of portfolio	48	Q1 2025 New
VIR Vir Biotechnology, Inc.	$728M	$0 0.0% of portfolio	60	Q1 2025 New
VRDN Viridian Therapeutics, Inc.\De	$680M	$0 0.0% of portfolio	34	Q1 2025 Reduced 60.0%
XNCR Xencor Inc	$541M	$0 0.0% of portfolio	39	Q1 2025 Reduced 70.0%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.